MILLER STRATEGIES, LLC

Lobbying for BRISTOL-MYERS SQUIBB COMPANY · Biopharmaceutical company

Filing Registration

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · posted Oct 6, 2025

Lobbying activity 2

Health Issues

Issues related to biosimilars reimbursement, supply chain and Medicare/Medicaid payment reform.

Medicare/Medicaid

Issues related to biosimilars reimbursement, supply chain and Medicare/Medicaid payment reform.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.